[Treatment of INH resistant tuberculo-pneumoconiosis with the rifampicin-ethambutol combination].
D004338:Drug Combinations; D004352:Drug Resistance, Microbial; D004977:Ethambutol / Q000627:therapeutic use*; D005500:Follow-Up Studies; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use*; D012293:Rifampin / Q000627:therapeutic use*; D012830:Silicotuberculosis / Q000188:drug therapy*; D013183:Sputum / Q000382:microbiology
D004338:Drug Combinations; D004977:Ethambutol; D007538:Isoniazid; D012293:Rifampin
Le traitement des tuberculo-pneumoconioses I.N.H. résistantes par l'association rifampicine-ethambutol.